Heidelberg Pharma AG's total assets for Q2 2026 were €46.90M, an increase of 22.97% from the previous quarter. CH:HPHA total liabilities were €61.11M for the fiscal quarter, a 24.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.